Trials / Completed
CompletedNCT02919995
A Study of RPL554 in Patients With Cystic Fibrosis
A Phase IIa, Randomised, Double Blind, Placebo Controlled, Three Way Crossover Study to Assess the Pharmacokinetics of RPL554 Administered to Adult Patients With Cystic Fibrosis.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Verona Pharma plc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates two doses of RPL554 and placebo in adult patients with cystic fibrosis. All patients receive all three treatments in a randomised sequence.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | RPL554 | RPL554 suspension administered using a nebuliser |
| DRUG | Placebo | Placebo solution administered using a nebuliser |
Timeline
- Start date
- 2017-02-08
- Primary completion
- 2017-11-03
- Completion
- 2017-11-03
- First posted
- 2016-09-30
- Last updated
- 2024-05-21
- Results posted
- 2019-03-20
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02919995. Inclusion in this directory is not an endorsement.